D uring the past decade, catheter ablation of atrial fibrillation (AF) has emerged as an important treatment option for patients with symptomatic AF refractory to antiarrhythmic drug therapy. Electric isolation of the pulmonary vein (PV isolation [PVI]) musculature has been identified as the primary end point for both catheter and surgical AF ablation procedures. 1 In fact, both the 2007 and the 2012 Heart Rhythm Society/ European Heart Rhythm Association (EHRA)/European Cardiac Arrhythmia Society (ECAS) Consensus Documents have both concluded that PVI is the cornerstone for most AF ablation procedures. 1
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In the present issue of Circulation: Arrhythmia and Electrophysiology, Zhao et al 2 report the results of a prospective randomized multicenter clinical trial examining the relative efficacy and safety of a novel non-PVI-based ablation strategy, referred to as pulmonary antrum radial-linear ablation (PAR) as compared with standard circumferential PVI for treatment of patients with paroxysmal AF. Forty-two patients underwent PAR ablation and 42 underwent PVI. These patients were followed closely at 3-month intervals using 3-day event and 24-hour Holter monitors. Ablation success was defined in accordance with the Heart Rhythm Society/ EHRA/ECAS Consensus Document as freedom from AF, flutter, tachycardia lasting 30 seconds or longer after a 3-month blanking period. 1 At 14 months of follow-up after a single procedure, 31 of 42 patients (74%) in the PAR ablation group had experienced no AF recurrence as compared with 22 of 44 patients (50%) treated with PVI. No major complications were observed in either arm of the study. The novel PAR ablation strategy consisted of creating 6 to 8 short linear spokes of ablation lesions emerging from the right and the left PV antrum. Importantly, circumferential PVI was not performed in the PAR group, and none of these patients demonstrated complete PVI. The ablation end point in the PAR group was completion of all the designed ablation lines, conversion of induced AF to sinus rhythm, and no inducible AF rendered using atrial burst pacing.
This striking study is a welcome addition to the literature on catheter and surgical AF ablation. I commend the authors for their enormous efforts to complete this novel clinical trial.
Despite the small number of patients, the duration, intensity of monitoring, and completeness of follow-up are to be commended. The remarkably low complication rate speaks to the expertise of the operators and centers and is also to be congratulated. In writing this editorial I am charged with helping to interpret the results of this study in the context of both my own experience with catheter ablation and the considerable body of previously published literature on catheter and surgical AF ablation. I would like to focus my comments on the critical issue as to whether the results of this and other studies should compel the electrophysiology community to abandon the long-held belief that PVI is the cornerstone of most AF ablation procedures.
The concept of PVI as an end point for AF ablation procedures was developed by Haïssaguerre et al. 3 After identification of the PVs as a common site of rapid atrial tachycardia which triggered AF, these investigators developed a strategy for AF ablation in which the end point of the procedure was electric isolation of the PV. During the ensuing 15 years since this observation was made, a large number of studies have been performed demonstrating that PVI results in a 60% to 80% success rate for ablation of paroxysmal AF. 1 The importance of PVI as an end point for AF ablation has gained widespread support over time based on clinical experience and clinical observations including the following. First, failure of AF ablation is almost universally accompanied by recurrence of PV conduction. Reisolation of PVs at the time of a repeat procedure results in an important increment in efficacy. Second, strategies which improve the durability of PVI, such as a postablation monitoring period, 4 pacing along the ablation line, 5 use of alternative energy sources, 6 and the use of surgical techniques, 7 improve the single procedure efficacy of AF ablation. And third, it has been demonstrated that double but not single lung transplantation provides long-term freedom from AF. 8 Despite the considerable body of clinical evidence cited above, which strongly support the importance of PVI, there is also a growing body of evidence which challenges the wellestablished concept of PVI as the cornerstone of AF ablation. Of particular note are the following 4 studies/observations. In 2002, Kottkamp et al 9 reported that a pure linear surgical ablation line that did not result in PVI resulted in elimination of AF in >90% of patients with paroxysmal or persistent AF. PVI was not performed. Nademanee 10 subsequently developed a novel ablation strategy targeting complex fractionated atrial electrograms. At 1-year follow-up more than three fourths of
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April 2013 patients were free of arrhythmia and symptom after a single ablation procedure. PVI was not performed. More recently, Narayan et al 11 have developed an ablation strategy which maps and targets localized sources (electric rotors and focal impulses). The use of this ablation strategy in conjunction with PVI resulted in improved efficacy as compared with PVI alone. The present study represents 1 additional ablation approach which achieved remarkable ablation success without specifically attempting or accomplishing electric isolation of the PVs. 2 At the end of the day, is it time to abandon PVI as the cornerstone for AF ablation? And is it time to embrace PAR ablation or another non-PVI-based ablation strategy as the new cornerstone of AF ablation? In my opinion the answer is not yet, and certainly not based on the results of a single small study. What is clear to all in this field is that more research is needed to better define the underlying mechanisms that initiate and perpetuate AF. Debate continues regarding the relative importance of trigger ablation, PVI, autonomic modulation, and substrate modification. 1 Although each of the 4 non-PVI-based (also referred to as substrate based) ablation procedures achieved high success, it is important to note that these 4 strategies differ widely in their approach. Furthermore, the impressive results of these studies have never been replicated or confirmed in larger multicenter clinical trials. I have long been of the belief that until we can achieve 100% durable PVI with a single ablation procedure, we will never be able to fully address the important question as to whether PVI alone is sufficient for ablation of AF patients, and especially those with paroxysmal AF. Those involved in this field are grateful to Zhao et al 2 for bringing forth the concept of PAR ablation for AF. In doing so, and in achieving such impressive results, they have forced all of us to continue the debate and hopefully to better defining the precise mechanisms by which AF is triggered and perpetuated. Further research is also needed in defining the relative efficacy and safety of PVI versus non-PV-based ablation strategies for treating patients with paroxysmal, persistent, and long-standing persistent AF.
